JP2012505172A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505172A5 JP2012505172A5 JP2011530451A JP2011530451A JP2012505172A5 JP 2012505172 A5 JP2012505172 A5 JP 2012505172A5 JP 2011530451 A JP2011530451 A JP 2011530451A JP 2011530451 A JP2011530451 A JP 2011530451A JP 2012505172 A5 JP2012505172 A5 JP 2012505172A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- total amount
- amount
- pharmaceutical
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 12
- 235000003599 food sweetener Nutrition 0.000 claims description 9
- 239000003765 sweetening agent Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 6
- 235000019408 sucralose Nutrition 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000010356 sorbitol Nutrition 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229960005489 paracetamol Drugs 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 7
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000006172 buffering agent Substances 0.000 claims 2
- 239000003086 colorant Substances 0.000 claims 2
- 239000002304 perfume Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08425654 | 2008-10-09 | ||
| EP08425654.4 | 2008-10-09 | ||
| PCT/EP2009/062501 WO2010040652A1 (en) | 2008-10-09 | 2009-09-28 | Liquid pharmaceutical formulation containing paracetamol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012505172A JP2012505172A (ja) | 2012-03-01 |
| JP2012505172A5 true JP2012505172A5 (OSRAM) | 2014-05-01 |
Family
ID=40282272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011530451A Pending JP2012505172A (ja) | 2008-10-09 | 2009-09-28 | パラセタモールを有する液体医薬製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120115958A1 (OSRAM) |
| EP (1) | EP2349207B1 (OSRAM) |
| JP (1) | JP2012505172A (OSRAM) |
| KR (1) | KR20110067103A (OSRAM) |
| CN (1) | CN102159184B (OSRAM) |
| AR (1) | AR073793A1 (OSRAM) |
| AU (1) | AU2009301296A1 (OSRAM) |
| BR (1) | BRPI0919796A2 (OSRAM) |
| CA (1) | CA2737391A1 (OSRAM) |
| EA (1) | EA018401B1 (OSRAM) |
| GE (1) | GEP20135723B (OSRAM) |
| MX (1) | MX2011003695A (OSRAM) |
| UA (1) | UA103906C2 (OSRAM) |
| WO (1) | WO2010040652A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013535451A (ja) * | 2010-07-21 | 2013-09-12 | アルコン リサーチ， リミテッド | 増強された溶解度特徴を有する薬学的組成物 |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| TN2017000232A1 (en) * | 2014-12-20 | 2018-10-19 | Troikaa Pharmaceuticals Ltd | Injectable formulations of paracetamol |
| CA3007286A1 (en) | 2015-12-22 | 2017-06-29 | Zogenix International Limited | Fenfluramine compositions and methods of preparing the same |
| EP3393470B1 (en) | 2015-12-22 | 2021-01-20 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
| MX2019001799A (es) | 2016-08-24 | 2019-06-13 | Zogenix International Ltd | Formulacion para inhibir la formacion de agonistas de 5-ht2b y metodos de utilizacion de la misma. |
| TWI620577B (zh) * | 2016-11-23 | 2018-04-11 | 乙醯胺酚及曲馬多共溶複方止痛口服液 | |
| US10682317B2 (en) * | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| GR1009462B (el) * | 2017-10-05 | 2019-02-15 | Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. | Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση |
| CN110115708A (zh) * | 2018-02-07 | 2019-08-13 | 保瑞药业股份有限公司 | 乙酰胺酚及曲马多共溶复方止痛口服液 |
| GR1009630B (el) * | 2018-03-14 | 2019-10-25 | Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. | Ποσιμα διαλυματα που περιλαμβανουν τραμαδολη και ακεταμινοφαινη |
| WO2019216919A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| WO2019241005A1 (en) | 2018-06-14 | 2019-12-19 | Zogenix International Limited | Compositions and methods for treating respiratory depression with fenfluramine |
| EA202191079A1 (ru) | 2018-11-19 | 2021-09-20 | Зодженикс Интернэшнл Лимитед | Способы лечения синдрома ретта с применением фенфлурамина |
| NL2024161B1 (en) * | 2019-11-05 | 2021-07-20 | Mperium B V | Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| US20230381101A1 (en) * | 2022-05-25 | 2023-11-30 | Boehringer Ingelheim Vetmedica Gmbh | Aqueous pharmaceutical compositions comprising sglt-2 inhibitors |
| ES3034164T3 (en) | 2022-11-08 | 2025-08-13 | Laboratorios Ern S A | Paracetamol oral solution |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
| US8128958B2 (en) * | 2003-11-10 | 2012-03-06 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
| US20080139528A1 (en) * | 2003-12-10 | 2008-06-12 | Pujara Chetan P | Cefdinir oral suspension |
| US20060093629A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
| WO2007070504A2 (en) * | 2005-12-13 | 2007-06-21 | Morton Grove Pharmaceuticals, Inc. | Stable and palatable oral liquid sumatriptan compositions |
| US20080085892A1 (en) * | 2006-08-31 | 2008-04-10 | Sangeetha Kandeepan | Liquid dosage form of acetaminophen |
-
2009
- 2009-09-28 MX MX2011003695A patent/MX2011003695A/es active IP Right Grant
- 2009-09-28 CN CN2009801367138A patent/CN102159184B/zh not_active Expired - Fee Related
- 2009-09-28 EP EP09818803.0A patent/EP2349207B1/en active Active
- 2009-09-28 AU AU2009301296A patent/AU2009301296A1/en not_active Abandoned
- 2009-09-28 GE GEAP200912218A patent/GEP20135723B/en unknown
- 2009-09-28 EA EA201170543A patent/EA018401B1/ru not_active IP Right Cessation
- 2009-09-28 JP JP2011530451A patent/JP2012505172A/ja active Pending
- 2009-09-28 KR KR1020117006413A patent/KR20110067103A/ko not_active Ceased
- 2009-09-28 BR BRPI0919796A patent/BRPI0919796A2/pt not_active IP Right Cessation
- 2009-09-28 US US13/062,536 patent/US20120115958A1/en not_active Abandoned
- 2009-09-28 WO PCT/EP2009/062501 patent/WO2010040652A1/en not_active Ceased
- 2009-09-28 CA CA2737391A patent/CA2737391A1/en not_active Abandoned
- 2009-09-28 UA UAA201102549A patent/UA103906C2/ru unknown
- 2009-10-08 AR ARP090103867A patent/AR073793A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505172A5 (OSRAM) | ||
| CN102159184B (zh) | 含有对乙酰氨基酚的液体药物制剂 | |
| CN100374112C (zh) | 罗替戈汀鼻内组合物 | |
| CN104411307B (zh) | 消旋卡多曲液体组合物 | |
| PT1998762E (pt) | Forma farmacêutica sólida contendo um agente activo de sabor mascarado | |
| US11129833B2 (en) | Methotrexate formulation | |
| RU2755087C1 (ru) | Композитный состав парацетамола для перорального применения | |
| TW201717932A (zh) | 雙醋瑞因或瑞因外用製劑及其用途 | |
| US20220248733A1 (en) | Formulations including dihydrohonokiol | |
| JP2002363105A (ja) | 不快な味のマスキング方法及び内服用液剤 | |
| JP6441669B2 (ja) | 液体口腔用組成物 | |
| JP6088151B2 (ja) | 医薬組成物 | |
| JP2017500357A (ja) | ラセカドトリル液体組成物 | |
| JP2003128583A (ja) | 清涼化組成物 | |
| JP2012508772A (ja) | 唾液分泌減退を緩和し口腔の快適性を提供するための組成物および方法 | |
| JP6410814B2 (ja) | フェキソフェナジンを含む経口投与用液体医薬組成物 | |
| US20120264776A1 (en) | Menthol liquids composition | |
| JP4403590B2 (ja) | ビタミンｂ１類配合液剤 | |
| CA2417258A1 (en) | Flavoring systems for pharmaceutical compositions and methods of making such compositions | |
| JP5514270B2 (ja) | アシタザノラスト含有組成物 | |
| JPH1036252A (ja) | ベラドンナ（総）アルカロイド配合内服液剤 | |
| JP2007106754A (ja) | アシタザノラスト含有組成物 | |
| JPH08333268A (ja) | カンゾウの抽出物を配合した安定な液剤 | |
| JP6114133B2 (ja) | クコシエキス含有内服液剤、可溶化剤および可溶化方法 | |
| JP2007217434A (ja) | 経口液剤 |